2012
Pregnancy and delivery following midurethral sling surgery for stress urinary incontinence
HUSER, Martin, Atanas-Ivan BELKOV, Petr JANKŮ a Kateřina SEDLÁKOVÁZákladní údaje
Originální název
Pregnancy and delivery following midurethral sling surgery for stress urinary incontinence
Autoři
HUSER, Martin (203 Česká republika, garant, domácí), Atanas-Ivan BELKOV (203 Česká republika, domácí), Petr JANKŮ (203 Česká republika, domácí) a Kateřina SEDLÁKOVÁ (203 Česká republika, domácí)
Vydání
International Journal of Gynecology and Obstetrics, 2012, 0020-7292
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30214 Obstetrics and gynaecology
Stát vydavatele
Irsko
Utajení
není předmětem státního či obchodního tajemství
Impakt faktor
Impact factor: 1.836
Kód RIV
RIV/00216224:14110/12:00061045
Organizační jednotka
Lékařská fakulta
UT WoS
000309895700004
Klíčová slova anglicky
Cesarean delivery; Delivery; Midurethral sling; Pregnancy; Stress urinary incontinence
Příznaky
Mezinárodní význam
Změněno: 13. 10. 2013 13:21, prof. MUDr. Martin Huser, Ph.D., MBA
Anotace
V originále
Objective: To analyze the available clinical evidence on the continued effectiveness of midurethral sling (MUS) surgery for stress urinary incontinence (SUI) in women who become pregnant and undergo delivery, and then to determine the optimal mode of delivery for such women. Methods: An online search was carried out to retrieve the available evidence regarding the risk of SUI recurrence during pregnancy and after delivery following a successful MUS treatment. Appropriate keywords were used to identify all relevant reports published from 1996 through 2011. Basic patient characteristics, mode of delivery, and presence of SUI during pregnancy and the postpartum were analyzed. Results: No more than 36 relevant cases were found. The overall urinary continence rates were 91.7% during pregnancy and 80.6% during the postpartum. Most (58.3%) of the women were delivered vaginally. Conclusion: The evidence indicates that the risk of SUI recurrence is not significantly different after a vaginal or a cesarean delivery. In women successfully treated with a MUS, pregnancy care and delivery mode therefore need to be considered case by case, according to factors other than the risk of recurrence.